المؤلفون: Di T; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; Department of Experimental Research, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China., Luo QY; Department of Clinical Research, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China., Song JT; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China., Yan XL; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Center of Molecular Medicine, Stockholm, Sweden., Zhang L; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; Department of Clinical Laboratory, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China., Pan WT; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China., Guo Y; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China., Lu FT; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China., Sun YT; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China., Xia ZF; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China., Yang LQ; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; Department of Experimental Research, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China., Qiu MZ; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; Department of Experimental Research, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. Electronic address: qiumzh@sysucc.org.cn., Yang DJ; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; Department of Experimental Research, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. Electronic address: yangdj@sysucc.org.cn., Sun J; Department of Clinical Research, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China. Electronic address: sjian@mail.sysu.edu.cn.

المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Sep 30; Vol. 139, pp. 112615. Date of Electronic Publication: 2024 Jul 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology , Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/metabolism , Carcinoma, Hepatocellular*/pathology , Anilides*/pharmacology , Anilides*/therapeutic use , Pyridines*/pharmacology , Pyridines*/therapeutic use , bcl-X Protein*/metabolism , Mice, Nude* , Xenograft Model Antitumor Assays* , Cell Proliferation*/drug effects, Animals ; Humans ; Cell Line, Tumor ; Mice ; Apoptosis/drug effects ; Cell Movement/drug effects ; Cyclic AMP Response Element-Binding Protein/metabolism ; Mice, Inbred BALB C ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; MAP Kinase Signaling System/drug effects ; Signal Transduction/drug effects ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Male

المؤلفون: Wang L; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China; State Key Laboratory of Bioactive Molecules and Druggability Assessment, MOE Key Laboratory of Tumor Molecular Biology, and Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, China; Zhuhai Institute of Jinan University, Zhuhai, China., Lin Y; State Key Laboratory of Bioactive Molecules and Druggability Assessment, MOE Key Laboratory of Tumor Molecular Biology, and Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, China; Zhuhai Institute of Jinan University, Zhuhai, China; Department of Thoracic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China; Department of Hematology, University of Groningen, University Medical Center Groningen, the Netherlands; Shantou University Medical College, Shantou, China., Yao Z; State Key Laboratory of Bioactive Molecules and Druggability Assessment, MOE Key Laboratory of Tumor Molecular Biology, and Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, China; Zhuhai Institute of Jinan University, Zhuhai, China; Department of Urology Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China., Babu N; Shantou University Medical College, Shantou, China., Lin W; Shantou University Medical College, Shantou, China., Chen C; Shantou University Medical College, Shantou, China., Du L; State Key Laboratory of Bioactive Molecules and Druggability Assessment, MOE Key Laboratory of Tumor Molecular Biology, and Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, China; Zhuhai Institute of Jinan University, Zhuhai, China., Cai S; Department of Thoracic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China., Pan Y; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China., Xiong X; State Key Laboratory of Bioactive Molecules and Druggability Assessment, MOE Key Laboratory of Tumor Molecular Biology, and Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, China; Zhuhai Institute of Jinan University, Zhuhai, China., Ye Q; State Key Laboratory of Bioactive Molecules and Druggability Assessment, MOE Key Laboratory of Tumor Molecular Biology, and Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, China; Zhuhai Institute of Jinan University, Zhuhai, China., Ren H; Department of Pathology, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China; Department of Pathology, Heping Hospital, Changzhi Medical College, Changzhi, China., Zhang D; Department of Biomedical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA., Chen Y; Department of Thyroid, Breast and Hernia Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China., Yeung SJ; Department of Emergency Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bremer E; Department of Hematology, University of Groningen, University Medical Center Groningen, the Netherlands., Zhang H; Department of Pathology, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China; State Key Laboratory of Bioactive Molecules and Druggability Assessment, MOE Key Laboratory of Tumor Molecular Biology, and Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, China; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China; Department of Thyroid, Breast and Hernia Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China. Electronic address: haolabcancercenter@163.com.

المصدر: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy [Drug Resist Updat] 2024 Sep; Vol. 76, pp. 101118. Date of Electronic Publication: 2024 Jul 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 9815369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2084 (Electronic) Linking ISSN: 13687646 NLM ISO Abbreviation: Drug Resist Updat Subsets: MEDLINE

مواضيع طبية MeSH: Trastuzumab*/pharmacology , Drug Resistance, Neoplasm*/drug effects , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Receptor, ErbB-2*/metabolism , Receptor, ErbB-2*/antagonists & inhibitors , Xenograft Model Antitumor Assays* , Nanoparticles*/chemistry, Humans ; Animals ; Mice ; Female ; Cell Line, Tumor ; Mice, Transgenic ; Antineoplastic Agents, Immunological/pharmacology ; Receptor-Like Protein Tyrosine Phosphatases, Class 3/metabolism ; Receptor-Like Protein Tyrosine Phosphatases, Class 3/antagonists & inhibitors ; Receptor-Like Protein Tyrosine Phosphatases, Class 3/genetics ; Signal Transduction/drug effects

المؤلفون: Fang T; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; Department of Comparative Medicine, Affiliated Hospital of Medicine School, Nanjing Jinling Hospital, Nanjing University, Nanjing, 210002, China., Hu S; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China., Song X; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China., Wang J; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China., Zuo R; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China., Yun S; Department of Comparative Medicine, Affiliated Hospital of Medicine School, Nanjing Jinling Hospital, Nanjing University, Nanjing, 210002, China., Jiang S; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China. jiangshanxiang@163.com.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China. jiangshanxiang@163.com., Guo D; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China. gdawei0123@njau.edu.cn.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China. gdawei0123@njau.edu.cn.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Sep; Vol. 207 (2), pp. 435-451. Date of Electronic Publication: 2024 Jul 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Erlotinib Hydrochloride*/pharmacology , Erlotinib Hydrochloride*/administration & dosage , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/metabolism , Neoplastic Stem Cells*/drug effects , Neoplastic Stem Cells*/metabolism , ErbB Receptors*/metabolism , ErbB Receptors*/antagonists & inhibitors , Signal Transduction*/drug effects , Monensin*/pharmacology , Cell Proliferation*/drug effects , Xenograft Model Antitumor Assays* , Drug Synergism*, Humans ; Animals ; Female ; Mice ; Cell Line, Tumor ; Phosphatidylinositol 3-Kinases/metabolism ; Cell Movement/drug effects ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Mice, Nude

المؤلفون: Fuchs V; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel., Sobarzo A; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel., Msamra M; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel., Kezerle Y; Institute of Pathology, Soroka University Medical Center, Beer-Sheva, Israel., Linde L; Biomedical Core Facility, Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology, Haifa, Israel., Sevillya G; Biomedical Core Facility, Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology, Haifa, Israel., Anoze A; The Oncology Institute, Helmsley Cancer Center, Precision Oncology and Innovation, Shaare Zedek Medical Center, 12, Shmuel Beit St, 9103102, Jerusalem, Israel., Refaely Y; Department of Cardiothoracic Surgery, Soroka University Medical Center, Beer-Sheva, Israel., Cohen AY; The Oncology Institute, Soroka University Medical Center, Beer-Sheva, Israel., Melamed I; Department of Neurosurgery, Soroka University Medical Center, Beer Sheva, Israel., Azriel A; Department of Neurosurgery, Soroka University Medical Center, Beer Sheva, Israel., Shoukrun R; Department of Ears, Nose & Throat, Head & Neck Surgery, Soroka University Medical Center, Beer Sheva, Israel., Raviv Y; Pulmonary Institute, Soroka University Medical Center, Beer-Sheva, Israel., Porgador A; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel., Peled N; The Oncology Institute, Helmsley Cancer Center, Precision Oncology and Innovation, Shaare Zedek Medical Center, 12, Shmuel Beit St, 9103102, Jerusalem, Israel. nirp@szmc.org.il., Roisman LC; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. dr.roisman@gmail.com.; The Oncology Institute, Helmsley Cancer Center, Precision Oncology and Innovation, Shaare Zedek Medical Center, 12, Shmuel Beit St, 9103102, Jerusalem, Israel. dr.roisman@gmail.com.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Sep; Vol. 26 (9), pp. 2227-2239. Date of Electronic Publication: 2024 Mar 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/therapy , Precision Medicine*/methods , Xenograft Model Antitumor Assays*, Animals ; Humans ; Mice ; Female ; Male ; Middle Aged ; Aged ; Exome Sequencing ; Disease Models, Animal

المؤلفون: Ran X; Guizhou University of Traditional Chinese Medicine, Guiyang, China., Hu A; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China.; The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China., Kuang Y; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China.; The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China., Wang C; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China.; The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China., Liu W; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China.; The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China., Xiao X; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China.; The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China., Zacksenhaus E; Department of Medicine, Laboratory Medicine & Pathobiology and Medical Biophysics, University of Toronto, Toronto, ON, M5G 1L1, Canada.; Division of Advanced Diagnostics, Toronto General Research Institute, University Health Network, Toronto, ON, Canada., Yu X; Guizhou University of Traditional Chinese Medicine, Guiyang, China. Xiangdi_Yu@163.com.; Anesthesiology Department of Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou, 545000, Guangxi, China. Xiangdi_Yu@163.com., Ben-David Y; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, Guizhou, People's Republic of China. yaacovbendavid@hotmail.com.; The Natural Products Research Center of Guizhou Province, Guiyang, Guizhou, People's Republic of China. yaacovbendavid@hotmail.com.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Sep; Vol. 207 (2), pp. 405-415. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Kruppel-Like Transcription Factors*/metabolism , Kruppel-Like Transcription Factors*/genetics , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Breast Neoplasms*/genetics , Breast Neoplasms*/drug therapy , Xenograft Model Antitumor Assays* , Cell Proliferation*/drug effects , Apoptosis*/drug effects , Cell Movement*/drug effects, Humans ; Animals ; Female ; Mice ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic/drug effects ; Antineoplastic Agents/pharmacology ; Disease Progression ; Disease Models, Animal

المؤلفون: Cox KE; Department of Surgery, University of California San Diego, La Jolla, CA, USA.; VA San Diego Healthcare System, San Diego, CA, USA., Turner MA; Department of Surgery, University of California San Diego, La Jolla, CA, USA.; VA San Diego Healthcare System, San Diego, CA, USA., Lwin TM; Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA, USA., Amirfakhri S; Department of Surgery, University of California San Diego, La Jolla, CA, USA.; VA San Diego Healthcare System, San Diego, CA, USA., Kelly KJ; Department of Surgical Oncology, University of Wisconsin, Madison, WI, USA., Hosseini M; Department of Pathology, University of California San Diego, La Jolla, CA, USA., Ghosh P; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.; Department of Medicine, University of California San Diego, La Jolla, CA, USA., Obonyo M; Department of Medicine, University of California San Diego, La Jolla, CA, USA., Hoffman RM; Department of Surgery, University of California San Diego, La Jolla, CA, USA.; VA San Diego Healthcare System, San Diego, CA, USA.; AntiCancer Inc, San Diego, CA, USA., Yazaki PJ; Department of Immunology & Theranostics, Beckman Research Institute of the City of Hope, Duarte, CA, USA., Bouvet M; Department of Surgery, University of California San Diego, La Jolla, CA, USA. mbouvet@ucsd.edu.; VA San Diego Healthcare System, San Diego, CA, USA. mbouvet@ucsd.edu.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2024 Sep; Vol. 31 (9), pp. 6291-6299. Date of Electronic Publication: 2024 Jun 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/surgery , Stomach Neoplasms*/pathology , Stomach Neoplasms*/immunology , Stomach Neoplasms*/diagnostic imaging , Carcinoembryonic Antigen*/immunology , Adenocarcinoma*/surgery , Adenocarcinoma*/pathology , Adenocarcinoma*/immunology , Adenocarcinoma*/diagnostic imaging , Xenograft Model Antitumor Assays* , Antibodies, Monoclonal, Humanized* , Fluorescent Dyes*, Animals ; Humans ; Mice ; Tumor Cells, Cultured ; Female ; Indoles ; Optical Imaging/methods ; Gastrectomy ; Mice, Nude ; Cell Line, Tumor

المؤلفون: Yadav M; Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India., Kandhari K; Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India., Mathan SV; Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India., Ali M; Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India., Singh RP; Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.; Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India.; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.

المصدر: Molecular carcinogenesis [Mol Carcinog] 2024 Sep; Vol. 63 (9), pp. 1697-1711. Date of Electronic Publication: 2024 May 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE

مواضيع طبية MeSH: Flavonols*/pharmacology , Apoptosis*/drug effects , G2 Phase Cell Cycle Checkpoints*/drug effects , Flavonoids*/pharmacology , Cyclin-Dependent Kinase Inhibitor p21*/metabolism , Cyclin-Dependent Kinase Inhibitor p21*/genetics , Xenograft Model Antitumor Assays* , Squamous Cell Carcinoma of Head and Neck*/drug therapy , Squamous Cell Carcinoma of Head and Neck*/metabolism , Squamous Cell Carcinoma of Head and Neck*/pathology , Cyclin-Dependent Kinase Inhibitor p27*/metabolism, Humans ; Animals ; Mice ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Mice, Nude ; Caspases/metabolism ; Head and Neck Neoplasms/drug therapy ; Head and Neck Neoplasms/metabolism ; Head and Neck Neoplasms/pathology ; Signal Transduction/drug effects ; DNA Damage/drug effects

المؤلفون: Kuang S; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang J; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Huang N; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang J; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Chen B; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wang L; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Liu M; Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

المصدر: Molecular carcinogenesis [Mol Carcinog] 2024 Sep; Vol. 63 (9), pp. 1738-1749. Date of Electronic Publication: 2024 Jun 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/radiotherapy , Carcinoma, Hepatocellular*/metabolism , Phenylurea Compounds*/pharmacology , Phenylurea Compounds*/therapeutic use , Pyridines*/pharmacology , Pyridines*/therapeutic use , Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/radiotherapy , Liver Neoplasms*/metabolism , Cell Proliferation*/drug effects , Xenograft Model Antitumor Assays* , Apoptosis*/drug effects, Animals ; Humans ; Mice ; Cell Line, Tumor ; STAT3 Transcription Factor/metabolism ; Mice, Nude ; Signal Transduction/drug effects ; Mice, Inbred BALB C ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Male ; Gene Expression Regulation, Neoplastic/drug effects

المؤلفون: Conway PJ; Department of Molecular Immunology & Microbiology, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas, USA; Department of Biomedical Sciences, Keiser University, 2600 N Military Trl, West Palm Beach, Florida, USA., De La Peña Avalos B; Greehey Children's Cancer Research Institute, University of Texas Health Science Center San Antonio, 8403 Floyd Curl Dr, San Antonio, Texas, USA., Dao J; Long School of Medicine, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas, USA., Montagnino S; Department of Molecular Immunology & Microbiology, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas, USA., Kovalskyy D; Greehey Children's Cancer Research Institute, University of Texas Health Science Center San Antonio, 8403 Floyd Curl Dr, San Antonio, Texas, USA., Dray E; Greehey Children's Cancer Research Institute, University of Texas Health Science Center San Antonio, 8403 Floyd Curl Dr, San Antonio, Texas, USA; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas, USA. Electronic address: dray@uthscsa.edu., Mahadevan D; Mays Cancer Center, University of Texas Health Science Center San Antonio, 7979 Wurzbach Rd, San Antonio, Texas, USA. Electronic address: mahadevand@uthscsa.edu.

المصدر: Neoplasia (New York, N.Y.) [Neoplasia] 2024 Sep; Vol. 55, pp. 101014. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5586 (Electronic) Linking ISSN: 14765586 NLM ISO Abbreviation: Neoplasia Subsets: MEDLINE

مواضيع طبية MeSH: Azepines*/pharmacology , Polyploidy* , Aurora Kinase A*/antagonists & inhibitors , Aurora Kinase A*/genetics , Pyrimidines*/pharmacology , Lymphoma, Large B-Cell, Diffuse*/drug therapy , Lymphoma, Large B-Cell, Diffuse*/genetics , Lymphoma, Large B-Cell, Diffuse*/pathology , Xenograft Model Antitumor Assays* , Cell Cycle Proteins*/genetics , Cell Cycle Proteins*/antagonists & inhibitors , Cell Cycle Proteins*/metabolism, Humans ; Animals ; Mice ; Cell Line, Tumor ; Apoptosis/drug effects ; Protein Kinase Inhibitors/pharmacology ; Cell Cycle/drug effects ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; Nuclear Proteins/antagonists & inhibitors ; Microtubule-Associated Proteins

المؤلفون: Liu T; Department of Pediatrics and Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, 30322, USA., Gu L; Department of Pediatrics and Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, 30322, USA., Mui A; Department of Pediatrics and Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, 30322, USA., Wu Z; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Albadari N; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, 38163, USA., Li W; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, 38163, USA. Electronic address: wli@uthsc.edu., Zhou M; Department of Pediatrics and Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, 30322, USA. Electronic address: mzhou@emory.edu.

المصدر: Cancer letters [Cancer Lett] 2024 Aug 28; Vol. 598, pp. 217126. Date of Electronic Publication: 2024 Jul 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

مواضيع طبية MeSH: Proto-Oncogene Proteins c-mdm2*/metabolism , Proto-Oncogene Proteins c-mdm2*/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/metabolism , Apoptosis*/drug effects , Xenograft Model Antitumor Assays* , Mice, SCID* , Tumor Suppressor Protein p53*/metabolism , Tumor Suppressor Protein p53*/genetics, Humans ; Animals ; Cell Line, Tumor ; Antineoplastic Agents/pharmacology ; Cell Proliferation/drug effects ; Proteolysis/drug effects ; X-Linked Inhibitor of Apoptosis Protein/genetics ; X-Linked Inhibitor of Apoptosis Protein/metabolism ; Dose-Response Relationship, Drug ; Mice ; Female ; Structure-Activity Relationship